Menopausal symptoms controlled by red clover

24 September 2006

The results of a study of US biotechnology firm Novogen's product Promensil (red clover), demonstrate its efficacy as a treatment for the symptoms of menopause, particularly in its control of hot flashes. The data, which were originally published in the Journal of Obstetrics & Gynecology of Canada in April this year, was authored by eight women's health experts, and concluded that over-the-counter supplements like red clover should be used early on in the treatment of menopause.

The study also proposes a system of treatments for menopausal symptoms that varies based on their severity. The research recommends a range of lifestyle changes such as smoking cessation and exercising advice, through to the use of supplements that have demonstrated efficacy, only advocating the use of hormone therapy in the most "extreme cases."

Lead study author Lila Nachtigall, a professor of obstetrics and gynecology at New York University's School of Medicine, explained that "hot flashes are the leading reason menopausal women seek treatment during menopause. In our research, we found a growing trend away from prescription hormone therapy in women with mild-to-moderate symptoms and an increasing trend towards lifestyle modifications and complementary therapies."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight